Laboratory revenue cycle management encompasses every operational process connecting clinical laboratory services to collected Medicare reimbursement – and in August 2026, it has become the most actionable lever available to laboratory executives preparing for a confirmed payment shift. The Consolidated Appropriations Act, 2026, signed February 3, 2026, delayed all PAMA-related Clinical Laboratory Fee Schedule (CLFS) rate reductions through December 31, 2026 – the seventh Congressional intervention since PAMA was enacted [1]. But the reprieve is temporary.

Most of what gets called a coding problem is not a coding problem. It is a documentation problem that surfaces in the co...
read more
CMS finalized the 2026 Medicare Physician Fee Schedule (MPFS) in October 2025, with policies effective January 1, 2026. ...
read more
You’re leaving $25-$40 per visit on the table every time a legitimate 99214 gets downcoded to 99213. Not because someone...
read more
Your pathologists are diagnosing cancer. But your billing team? They’re diagnosing something else entirely: denials, und...
read more
You’re wrapping up a 10-hour shift. One more note to finish, one last patient to call – and then someone from billing wa...
read more
The medical billing outsourcing market is experiencing unprecedented growth, with the global market size projected to re...
read more
In the wake of COVID, budget crunches, and labor shortages, many hospitals and health systems have been making the smart...
read more
Physician billing companies know a secret – keeping on top of risks in physician billing services is one of the most eff...
read more
Next year promises interesting changes for the Medicare Physician Fee Schedule — many of which will help medical billers...
read more